Literature DB >> 6438833

Verapamil: failure of metabolic amelioration following global forebrain ischemia in the rat.

J R Berger, R Busto, M D Ginsberg.   

Abstract

The potential efficacy of the calcium channel blocker verapamil in modifying ischemic brain injury was evaluated in anesthetized rats subjected to 60 or 90 min of diffuse forebrain ischemia produced by bilateral occlusion of the carotid and vertebral arteries. Treated animals received verapamil, 2 mg/kg intravenously, prior to ischemia. Four hours of postischemic recirculation was permitted by reversing the carotid occlusions. Intermittent high-voltage slow-wave activity was noted on electroencephalograms shortly after verapamil infusion, prior to ischemia. The ischemic insult induced an isoelectric EEG, which tended to persist during recirculation in both treated and untreated animals. Similarly, verapamil pretreatment failed to influence brain water content or cerebral energy metabolites (phosphocreatine, ATP, ADP, AMP) or cerebral energy charge when assayed after four hours of recirculation. Thus, verapamil failed to confer a protective effect on brain electrical activity, water content, or energy metabolites following ischemia in this model.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438833     DOI: 10.1161/01.str.15.6.1029

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Time-course of changes in water, sodium, potassium and calcium contents of various brain regions in rats after systemic kainic acid administration.

Authors:  L Sztriha; F Joó; P Szerdahelyi
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke.

Authors:  Michael E Maniskas; Jill M Roberts; Ishi Aron; Justin F Fraser; Gregory J Bix
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

Review 3.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

Authors:  Surojit Paul; Eduardo Candelario-Jalil
Journal:  Exp Neurol       Date:  2020-11-02       Impact factor: 5.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.